|
|
|
|
| LEADER |
03677nam a22003493i 4500 |
| 001 |
EBC30733622 |
| 003 |
MiAaPQ |
| 005 |
20231204023231.0 |
| 006 |
m o d | |
| 007 |
cr cnu|||||||| |
| 008 |
231204s2023 xx o ||||0 eng d |
| 020 |
|
|
|a 9789240076600
|q (electronic bk.)
|
| 035 |
|
|
|a (MiAaPQ)EBC30733622
|
| 035 |
|
|
|a (Au-PeEL)EBL30733622
|
| 035 |
|
|
|a (OCoLC)1396699152
|
| 040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
| 245 |
1 |
0 |
|a GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection.
|
| 250 |
|
|
|a 1st ed.
|
| 264 |
|
1 |
|a Geneva :
|b World Health Organization,
|c 2023.
|
| 264 |
|
4 |
|c ©2023.
|
| 300 |
|
|
|a 1 online resource (72 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting.
|
| 505 |
8 |
|
|a References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators.
|
| 588 |
|
|
|a Description based on publisher supplied metadata and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2023. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|t GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection
|d Geneva : World Health Organization,c2023
|
| 797 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=30733622
|z Click to View
|
